- 令和
- 新型コロナウイルス
- マスク
- 感染症
- 母乳
- インフルエンザウイルス
- ベンチャー
- 世界初
- 会見
- 価格
「ナノ粒子」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 2
- 期間を指定 63
- 日付指定なし 63
- 種類
- 写真 57
- グラフィックス 6
- 映像 0
- 向き
- 縦 3
- 横 54
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 60
- モノクロ 3
- 古い順
- 1
- 古い順
2005年06月17日影響を調べる実験装置 ナノ粒子の影響調査へ自動車排出ガスに含まれるナノ粒子が生物の体に及ぼす影響を調べる実験装置＝１７日、茨城県つくば市の国立環境研究所
商品コード: 2005061700157
2016年09月09日説明する東阪助教 母乳介し子へもナノ粒子記者会見で説明する大阪大の東阪和馬助教＝９日午後、大阪市
商品コード: 2016090900784
2016年09月09日母乳介し子へもナノ粒子ナノ粒子が母乳を介して母マウスから子マウスに移行するイメージ
商品コード: 2016090900940
2016年09月09日母乳介し子へもナノ粒子ナノ粒子が母乳を介して母マウスから子マウスに移行するイメージ
商品コード: 2016090900939
2017年03月07日がん患部標的の粒子開発ナノ粒子が、がん患部にとどまるイメージ
商品コード: 2017030700930
2017年03月07日がん患部標的の粒子開発ナノ粒子が、がん患部にとどまるイメージ
商品コード: 2017030700931
2017年03月07日がん患部標的の粒子開発ナノ粒子が、がん患部にとどまるイメージ
商品コード: 2017030700932
2017年03月07日がん患部標的の粒子開発ナノ粒子が、がん患部にとどまるイメージ
商品コード: 2017030700934
2018年11月07日Award of the Berlin Science Prize 201807 November 2018, Berlin: Daniela Rupp, Leibnitz Young Investigators Group Leader at the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy, is at the award ceremony for the Berlin Science Prize 2018 and the Young Investigators Prize 2018 in the Rotes Rathaus. Rupp was awarded the Young Investigators Prize 2018 of the Berlin Science Prize for her current research in attosecond physics, also known as ultra-short time physics. In a number of projects, she and her team have been able to make progress in understanding the imaging and interaction of nanometer-sized particles using intense X-ray pulses. Photo: Christoph Soeder/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2018110925443
2018年11月07日Award of the Berlin Science Prize 201807 November 2018, Berlin: Daniela Rupp, Leibnitz Young Investigators Group Leader at the Max Born Institute for Nonlinear Optics and Short Pulse Spectroscopy, is at the award ceremony for the Berlin Science Prize 2018 and the Young Investigators Prize 2018 in the Rotes Rathaus. Rupp was awarded the Young Investigators Prize 2018 of the Berlin Science Prize for her current research in attosecond physics, also known as ultra-short time physics. In a number of projects, she and her team have been able to make progress in understanding the imaging and interaction of nanometer-sized particles using intense X-ray pulses. Photo: Christoph Soeder/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2018110924653
2020年04月08日Company Respilon, face mask, with copper oxidesRespilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902051
2020年04月08日JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxidesRespilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902036
2020年04月08日Company Respilon, face mask, with copper oxidesRespilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902038
2020年04月08日Company Respilon, face mask, with copper oxidesRespilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902061
2020年04月08日Company Respilon, face mask, with copper oxidesRespilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902066
2020年04月08日Company Respilon, face mask, with copper oxidesRespilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902063
2020年04月08日JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxidesRespilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902035
2020年04月08日Company Respilon, face mask, with copper oxidesRespilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902067
2020年04月08日JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxidesRespilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902057
2020年04月08日Company Respilon, face mask, with copper oxidesRespilon company presents new project during the briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902074
2020年04月08日JANA ZIMOVA, owner, Company Respilon, face mask, with copper oxidesRespilon company representative Jana Zimova gives a briefing in Czech Technology Park, where company plans manufacturing lines capable of producing 100,000 nanoparticle respirators and face masks capable of protecting against the novel coronavirus, in Brno, Czech Republic, April 8, 2020. (CTK Photo/Vaclav Salek)、クレジット：ＣＴＫ／共同通信イメージズ
商品コード: 2020040902055
2020年09月07日渋谷工業とスディックスバイオがＰＣＲ検査装置開発で会見渋谷工業はスディックスバイオテック（鹿児島市）と共同で、一つの唾液検体から新型コロナウイルスとインフルエンザウイルスＡ型・Ｂ型の感染を１５分程度で診断できる世界初のＰＣＲ検査装置を開発し、年内をめどに発売する。価格は未定だが「開業医でも購入できる」（隅田泰生スディックスバイオテック社長）２００万円以下を目指し、初年度は数百台の販売を見込む。スディックスバイオテックは鹿児島大学発のベンチャーで、唾液から検体を採取する独自のウイルスの検査方法「糖鎖固定化磁性金ナノ粒子（ＳＭＧＮＰ）法」を開発している。同検査法は検体の前処理工程を３分程度で完了するため、新開発するＰＣＲ検査装置との併用で従来法から大幅に検査時間を短縮できる。また、一度に８検体の検査が可能な小型の装置に仕上げ、個人の開業医院での運用を同時に提案していく。装置は渋谷工業が製造し、国内販売はスディックスバイオテック、海外販売は渋谷工業が行う。写真は握手する毛利克己渋谷工業専務（左）と隅田泰生スディックスバイオテック社長 ＝２０２０（令和２）年９月７日撮影、撮影場所不明、クレジット：日刊工業新聞／共同通信イメージズ
商品コード: 2020091805148
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) and Manager Director of Pfizer Puurs, Luc Van Steenwinkel (R) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106281
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (C) and Manager Director of Pfizer Puurs, Luc Van Steenwinkel (R) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106373
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106344
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040104882
2021年03月30日King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - BelgiumKing Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040702527
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033107143
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033107110
2021年03月30日King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - BelgiumKing Philippe of Belgium (L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040702598
2021年03月30日King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - BelgiumKing Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040702517
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033107878
2021年03月30日King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - BelgiumKing Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040702495
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033107741
2021年03月30日King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - BelgiumKing Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040702499
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033107843
2021年03月30日King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - BelgiumKing Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040702422
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106385
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106205
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033107796
2021年03月30日King Philippe Visits Pfizer-BioNTech - Belgium King Philippe Visits Pfizer-BioNTech - BelgiumKing Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, March 30, 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by Stephanie Lecocq/Pool/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040702605
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033107287
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106269
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106548
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040105172
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (C) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106552
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106576
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106371
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs , Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106424
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (3L) and Manager Director of Pfizer Puurs , Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106369
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (3L) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106561
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (3L) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (2L) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106411
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (not seen) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106259
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel (not seen) listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106375
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (not seen) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106381
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106447
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106539
2021年03月30日King Philippe Visits Pfizer-BioNTech Vaccine Production Site - Puurs King Philippe Visits Pfizer-BioNTech Vaccine Production Site - PuursKing Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. Photo by STEPHANIE LECOCQ/POOL/Reporters/ABACAPRESS.COM＝２０２１（令和３）年３月３０日、クレジット：Ｒｅｐｏｒｔｅｒｓ／ＡＢＡＣＡ／共同通信イメージズ
商品コード: 2021040106066
2021年03月30日King Philippe of Belgium visits the Pfizer-BioNTech vaccine production site.March 30, 2021, PUURS, Belgium: King Philippe of Belgium (R) and Manager Director of Pfizer Puurs Luc Van Steenwinkel listen the explanations on LNP (Lipid Nano Particle) SKID machine during a visit to the Pfizer-BioNTech vaccine production site in Puurs, Belgium, 30 March 2021. The pharmaceutical group Pfizer is finalizing its mRNA-type vaccine on this site. Pfizer is also unveiling its new SKID machine, which encapsulates the active substance of the vaccine in lipids to keep it functioning efficiently. STEPHANIE LECOCQ/ POOL....Reporters / STAG (Credit Image: © Reporters via ZUMA Press)、クレジット：©Ｒｅｐｏｒｔｅｒｓ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021033106523
2021年06月14日COVID-19: MEDICAL: Vaccine CandidatesJune 14, 2021, Asuncion, Paraguay: Illustration photo of logo of Novavax, Inc. (Nasdaq: NVAX), an American biotechnology company, is displayed on smartphone in front of waving flag of United States, visual representation of virus, medical syringe and ampoules with label COVID-19 vaccine. Novavax, today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. (Credit Image: © Andre M. Chang/ZUMA Wire)、クレジット：©Ａｎｄｒｅ Ｍ． Ｃｈａｎｇ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021061510181
2021年06月14日COVID-19: MEDICAL: Vaccine CandidatesJune 14, 2021, Asuncion, Paraguay: Illustration photo of logo of Novavax, Inc. (Nasdaq: NVAX), an American biotechnology company, is displayed on smartphone in front of waving flag of United States, visual representation of virus, medical syringe and ampoules with label COVID-19 vaccine. Novavax, today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial. (Credit Image: © Andre M. Chang/ZUMA Wire)、クレジット：©Ａｎｄｒｅ Ｍ． Ｃｈａｎｇ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021061510061
2021年07月09日Expedition 65 SpaceX Crew 2 Aboard Space StationExpedition 65 Flight Engineer THOMAS PESQUET of ESA (European Space Agency) conducts a session for the InSPACE-4 physics study. The space manufacturing investigation takes place inside the Microgravity Science Glovebox and explores ways to harness nanoparticles to fabricate new and advanced materials.、クレジット：Ｅｘｐｅｄｉｔｉｏｎ ６５ Ｆｌｉｇｈｔ Ｅｎｇｉｎｅｅｒ ＴＨＯＭＡＳ ＰＥＳＱＵＥＴ ｏｆ ＥＳＡ （Ｅｕｒｏｐｅａｎ Ｓｐａｃｅ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021071605867
2021年08月10日Clinical trial of S. Korea‘s 1st homegrown vaccine candidateClinical trial of S. Korea‘s 1st homegrown vaccine candidate This file photo dated Oct. 15, 2020, shows vials of the coronavirus vaccine candidate revealed during a press conference at SK Bioscience Co., a vaccine development company, in Seongnam, south of Seoul. On Aug. 10, 2021, the government said SK has won approval to conduct the phase three clinical trial of the country‘s first homegrown vaccine candidate, GBP510, a recombinant-protein vaccine based on novel two-component nanoparticles that can maximize the immune effect. (Yonhap)/2021-08-10 16:15:28/＜Copyright ⓒ 1980-2021 YONHAPNEWS AGENCY. All rights reserved.＞＝クレジット：Ｙｏｎｈａｐ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021081105816
- 1
